Skip to main content
Year archive

Karolinska Development — 2019 filings

All 187 regulatory filings released by Karolinska Development (KDEV) in 2019, sourced directly from the official regulator.

187 Filings
2019 Period
2019 filings (187)
Filing Released Lang
Change of number of shares and votes in Karolinska Development
Share Issue/Capital Change
2019-12-30 English
Ändring av antal aktier och röster i Karolinska Development
Share Issue/Capital Change
2019-12-30 Swedish
Karolinska Development säkrar sitt kortsiktiga finansieringsbehov
Capital/Financing Update
2019-12-19 Swedish
Karolinska Development has secured its short-term financing needs
Capital/Financing Update
2019-12-19 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-18 English
Karolinska Development meddelar slutligt utfall i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-12-18 Swedish
Karolinska Development publishes an update on the net profit effect of the portfolio company Aprea Therapeutics share price development and a prospectus supplement relating to the directed share issue
Capital/Financing Update
2019-12-13 English
Karolinska Development offentliggör uppdatering av nettovinsteffekt av portföljbolaget Aprea Therapeutics aktiekursutveckling samt tilläggsprospekt avseende riktad nyemission till Bolagets konvertibel
Capital/Financing Update
2019-12-13 Swedish
Acquirer of SEK 121 million of convertible loan in Karolinska Development commits to set-off and the subscription period in the directed share issue is extended
Capital/Financing Update
2019-12-12 English
Förvärvare av 121 miljoner kronor konvertibellån i Karolinska Development ingår avtal om kvittning och teckningsperioden i den riktade nyemissionen förlängs
Capital/Financing Update
2019-12-12 Swedish
Karolinska Developments portföljbolag Forendo Pharma ingår licens- och samarbetsavtal med globalt läkemedelsföretag
M&A Activity
2019-12-11 Swedish
Karolinska Development’s portfolio company Forendo Pharma enters license and collaboration agreement with leading pharma company
M&A Activity
2019-12-11 English
Karolinska Development´s portfolio company Aprea Therapeutics presents data from two Phase Ib/II studies of APR-246 at the American Society of Hematology meeting
Earnings Release FY 2019
2019-12-09 English
Karolinska Developments portföljbolag Aprea Therapeutics presenterar data från två fas 1b/2-studier av APR-246 på ASH-kongressen
Regulatory Filings
2019-12-09 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-12-02 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-29 English
Ändring av antal aktier och röster i Karolinska Development
Share Issue/Capital Change
2019-11-29 Swedish
Change of number of shares and votes in Karolinska Development
Declaration of Voting Results & Voting Rights Announcements
2019-11-29 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-11-29 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-11-29 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-11-28 English
Karolinska Development announces the result of the first partial registration in the directed share issue to the Company's convertible loan holders
Share Issue/Capital Change
2019-11-20 English
Karolinska Development offentliggör utfall för den första delregistreringen i den riktade nyemissionen till Bolagets konvertibelinnehavare
Share Issue/Capital Change
2019-11-20 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-11-07 English
Karolinska Development offentliggör tilläggsprospekt avseende riktad nyemission till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-11-06 Swedish
Karolinska Development publishes prospectus supplement relating to the directed share issue to the Company’s convertible holders
Capital/Financing Update
2019-11-06 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-11-05 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-10-28 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-10-28 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-10-28 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-10-28 Swedish
Karolinska Development divests its ownership in Asarina Pharma
M&A Activity
2019-10-28 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-10-14 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Share Issue/Capital Change
2019-10-14 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-10-14 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-10-14 Swedish
Karolinska Development’s portfolio company OssDsign receives US FDA clearance for Cranial PSI Accessories
Regulatory Filings
2019-10-14 English
Karolinska Development’s portfolio company Aprea Therapeutics Announces Closing of Initial Public Offering
Share Issue/Capital Change
2019-10-08 English
Karolinska Developments portföljbolag Aprea Therapeutics har fastställt priset i sin börsnotering
Capital/Financing Update
2019-10-03 Swedish
Karolinska Development’s portfolio company Aprea Therapeutics has priced its initial public offering
Regulatory Filings
2019-10-03 English
Karolinska Development’s portfolio company Aprea Therapeutics has priced its initial public offering
Share Issue/Capital Change
2019-10-03 English
Karolinska Developments portföljbolag Aprea Therapeutics har fastställt priset i sin börsnotering
Share Issue/Capital Change
2019-10-03 Swedish
Karolinska Development publishes prospectus supplement relating to the directed share issue to the Company’s convertible holders
Capital/Financing Update
2019-09-27 English
Karolinska Development offentliggör tilläggsprospekt avseende riktad nyemission till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-27 Swedish
Karolinska Development offentliggör tilläggsprospekt avseende riktad nyemission till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-27 Swedish
Karolinska Development publishes prospectus supplement relating to the directed share issue to the Company’s convertible holders
Capital/Financing Update
2019-09-27 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-27 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-27 English
Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market
Regulatory Filings
2019-09-23 English
Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market
Regulatory Filings
2019-09-23 English
Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market
Regulatory Filings
2019-09-23 English
Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market
Regulatory Filings
2019-09-23 English
Karolinska Developments portfolio company Lipidor has been approved for listing on Nasdaq First North Growth Market
Report Publication Announcement
2019-09-23 English
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Developments portföljbolag Aprea Therapeutics fastställer prisintervallet för en potentiell börsnotering
Capital/Financing Update
2019-09-23 Swedish
Karolinska Development’s portfolio company Aprea Therapeutics sets price range for potential initial public offering
Capital/Financing Update
2019-09-23 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-12 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-12 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-12 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-12 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-09-12 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-09-12 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-09-12 English
Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission
Capital/Financing Update
2019-09-09 English
Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission
Capital/Financing Update
2019-09-09 English
Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission
Capital/Financing Update
2019-09-09 English
Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission
Capital/Financing Update
2019-09-09 English
Karolinska Development's portfolio company Aprea Therapeutics has filed a registration statement relating to its shares of common stock with the U.S. Securities and Exchange Commission
Capital/Financing Update
2019-09-09 English
Interim Report January - June 2019
Report Publication Announcement
2019-08-30 English
Interim Report January - June 2019
Report Publication Announcement
2019-08-30 English
Interim Report January - June 2019
Report Publication Announcement
2019-08-30 English
Interim Report January - June 2019
Report Publication Announcement
2019-08-30 English
Interim Report January - June 2019
Report Publication Announcement H1 2019
2019-08-30 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-29 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-29 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-29 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-29 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-29 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-29 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-08-29 English
Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant
Regulatory Filings
2019-08-28 English
Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant
Regulatory Filings
2019-08-28 English
Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant
Regulatory Filings
2019-08-28 English
Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant
Regulatory Filings
2019-08-28 English
Karolinska Development's portfolio company Promimic receives FDA approval for its HAnano Surface® on a spinal implant
Regulatory Filings
2019-08-28 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-08-28 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-08-26 English
Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
Regulatory Filings
2019-08-20 English
Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
Regulatory Filings
2019-08-20 English
Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
Regulatory Filings
2019-08-20 English
Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
Regulatory Filings
2019-08-20 English
Karolinska Development's portfolio company Forendo Pharma commences Phase 1b study of its drug candidate FOR-6219
Regulatory Filings
2019-08-20 English
New date for publication of Karolinska Developments Interim Report January – June 2019
Report Publication Announcement
2019-08-16 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-16 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-16 English
New date for publication of Karolinska Developments Interim Report January – June 2019
Report Publication Announcement
2019-08-16 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
New date for publication of Karolinska Developments Interim Report January – June 2019
Report Publication Announcement
2019-08-16 English
New date for publication of Karolinska Developments Interim Report January – June 2019
Report Publication Announcement
2019-08-16 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-16 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-16 English
New date for publication of Karolinska Developments Interim Report January – June 2019
Report Publication Announcement
2019-08-16 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update
2019-08-16 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-16 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-08-16 English
Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO
Board/Management Information
2019-08-05 English
Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO
Board/Management Information
2019-08-05 English
Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO
Board/Management Information
2019-08-05 English
Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO
Board/Management Information
2019-08-05 English
Karolinska Development's portfolio company Aprea Therapeutics appoints Scott Coiante as CFO
Board/Management Information
2019-08-05 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-08-02 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-08-02 Swedish
Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma
Capital/Financing Update
2019-07-19 English
Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma
Capital/Financing Update
2019-07-19 English
Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma
Capital/Financing Update
2019-07-19 English
Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma
Capital/Financing Update
2019-07-19 English
Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma
Capital/Financing Update
2019-07-19 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-07-19 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Share Issue/Capital Change
2019-07-19 English
Karolinska Development’s portfolio company Dilafor initiates Phase 2b clinical trial with tafoxiparin in women planned for labor induction
Regulatory Filings
2019-07-09 English
Karolinska Development’s portfolio company Dilafor initiates Phase 2b clinical trial with tafoxiparin in women planned for labor induction
Regulatory Filings
2019-07-09 English
Karolinska Development’s portfolio company Dilafor initiates Phase 2b clinical trial with tafoxiparin in women planned for labor induction
Regulatory Filings
2019-07-09 English
Karolinska Development’s portfolio company Dilafor initiates Phase 2b clinical trial with tafoxiparin in women planned for labor induction
Regulatory Filings
2019-07-09 English
Karolinska Development offentliggör prospekt avseenderiktad nyemission till Bolagets konvertibelinnehavare
Capital/Financing Update
2019-07-05 Swedish
Karolinska Development publishes prospectus relating to the directed share issue
Report Publication Announcement
2019-07-05 English
Karolinska Development appoints Fredrik Järrsten as Deputy CEO
Board/Management Information
2019-07-01 English
Karolinska Development appoints Fredrik Järrsten as Deputy CEO
Board/Management Information
2019-07-01 English
Karolinska Development appoints Fredrik Järrsten as Deputy CEO
Board/Management Information
2019-07-01 English
Karolinska Development appoints Fredrik Järrsten as Deputy CEO
Board/Management Information
2019-07-01 English
Karolinska Developments årsstämma 2019
AGM Information
2019-06-28 Swedish
Karolinska Development´s Annual General Meeting 2019
AGM Information
2019-06-28 English
Update concerning subscription undertakings in Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
AGM Information
2019-06-28 English
Update concerning subscription undertakings in Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
AGM Information
2019-06-28 English
Update concerning subscription undertakings in Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
AGM Information
2019-06-28 English
Update concerning subscription undertakings in Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
Capital/Financing Update
2019-06-28 English
Karolinska Development avyttrar sitt ägande i Pharmanest för 23 mkr
Capital/Financing Update
2019-06-27 Swedish
Karolinska Development sells its ownership in Pharmanest for SEK 23 million
M&A Activity
2019-06-27 English
Announcement of the final terms and conditions of Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
Capital/Financing Update
2019-06-26 English
Announcement of the final terms and conditions of Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
Capital/Financing Update
2019-06-26 English
Announcement of the final terms and conditions of Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
Capital/Financing Update
2019-06-26 English
Announcement of the final terms and conditions of Karolinska Development’s directed share issue to the holders of the Company’s convertible loan
Capital/Financing Update
2019-06-26 English
The Swedish Securities Council grants Sino Biopharmaceutical exemption from the mandatory bid obligation
Capital/Financing Update
2019-06-04 English
Notice of Annual General Meeting in Karolinska Development AB (publ)
AGM Information
2019-05-29 English
Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma
AGM Information
2019-05-29 Swedish
Karolinska Development changes date for the Annual General Meeting
AGM Information
2019-05-28 English
Karolinska Development’s portfolio company OssDsign reports substantial progress in the process towards reimbursement of OSSDSIGN PSI in France
Regulatory Filings
2019-05-23 English
Karolinska Developments portföljbolag OssDsign gör betydande framsteg i processen för inklusion av OSSDSIGN Cranial PSI i den franska sjukförsäkringen
Regulatory Filings
2019-05-23 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-21 Swedish
Management Reports 2019
Management Reports
2019-05-21 English
Karolinska Developments portföljbolag OssDsigns nyemission inför notering på Nasdaq First North är övertecknad
Share Issue/Capital Change
2019-05-20 Swedish
Karolinska Development’s portfolio company OssDsign’s share issue prior to listing on Nasdaq First North is oversubscribed
Share Issue/Capital Change
2019-05-20 English
Karolinska Development's portfolio company Modus Therapeutics announces results from a Phase 2 study of sevuparin in patients with sickle cell disease
Legal Proceedings Report
2019-05-13 English
Karolinska Developments portföljbolag Modus Therapeutics tillkännager resultat från en fas 2-studie av sevuparin i patienter med sicklecellsjukdom
Regulatory Filings
2019-05-13 Swedish
Karolinska Development’s portfolio company OssDsign applies for listing on Nasdaq First North
Report Publication Announcement
2019-05-02 English
Karolinska Developments portföljbolag OssDsign ansöker om notering på Nasdaq First North
Share Issue/Capital Change
2019-05-02 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-30 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-30 English
Karolinska Developments portföljbolag Dilafor säkrar finansiering inför fortsatt klinisk utveckling av tafoxiparin
Share Issue/Capital Change
2019-04-23 Swedish
Karolinska Development's portfolio company Dilafor secures financing for continued development of tafoxiparin
Share Issue/Capital Change
2019-04-23 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-18 English
Earnings Release 2018
Earnings Release Q4 2018
2019-02-14 Swedish
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-13 English
Karolinska Development's portfolio company Umecrine Cognition presents phase 2a results for GR3027 in idiopathic hypersomnia
Regulatory Filings
2019-01-29 English
Karolinska Developments portföljbolag Umecrine Cognition presenterar fas 2a resultat för GR3027 vid idiopatisk hypersomni
Regulatory Filings
2019-01-29 Swedish